Low-dose triple-pill cuts risk of recurrent stroke by about 40%, global trial shows

MedicalXpress | أبر 22, 2026

Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of another stroke in patients with intracerebral hemorrhage and high blood pressure. Results from the TRIDENT randomized controlled trial, led by The George Institute for Global Health, are published in The New England Journal of Medicine.